HCAT — Health Catalyst Income Statement
0.000.00%
- $294.18m
- $284.54m
- $306.58m
- 67
- 68
- 14
- 48
Annual income statement for Health Catalyst, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 189 | 242 | 276 | 296 | 307 |
Cost of Revenue | |||||
Gross Profit | 90.8 | 118 | 134 | 135 | 142 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 293 | 386 | 416 | 423 | 376 |
Operating Profit | -105 | -144 | -140 | -127 | -69.8 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -116 | -160 | -142 | -118 | -69.2 |
Provision for Income Taxes | |||||
Net Income After Taxes | -115 | -153 | -137 | -118 | -69.5 |
Net Income Before Extraordinary Items | |||||
Net Income | -115 | -153 | -137 | -118 | -69.5 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -115 | -153 | -137 | -118 | -69.5 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -2.72 | -2.82 | -2.45 | -1.63 | -1 |